Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Multiple Myeloma
100%
Immunogenic
100%
Long Peptides
100%
Dickkopf-1 (DKK1)
100%
CD4+
25%
Cell Response
25%
CD8+ T
25%
Myeloma Cells
16%
HLA-A*0201
16%
T Cells
8%
Immunogenicity
8%
Transgenic Mice
8%
Tumor Cells
8%
Amino Acids
8%
Cytotoxic T Lymphocytes
8%
CD8+ T Cells
8%
Epitope
8%
Transgenic Mouse Model
8%
HLA-DR
8%
Lysis
8%
Humoral Immunity
8%
CD4+ T Cells
8%
Human Blood
8%
Interferon-γ
8%
Short Peptides
8%
MHC Class II Molecules
8%
CD8+ Cells
8%
Fluorescein Diacetate
8%
Multiple Myeloma Patients
8%
MHC Class I Molecules
8%
Tetramer Staining
8%
Cytotoxic Assay
8%
Immunology and Microbiology
Immunotherapy
100%
Peptides
100%
Multiple Myeloma
100%
Cytotoxic T-Cell
40%
CD4
30%
Transgenic Mouse
20%
Myeloma Cell
20%
In Vitro
20%
Mouse Model
10%
Epitope
10%
T Cell
10%
Immunogenicity
10%
Secretion (Process)
10%
Cytotoxic T Cell
10%
Amino Acid
10%
T-Helper Cell
10%
HLA-DR
10%
Tumor Cell
10%
MHC Class I
10%
Humoral Immunity
10%
MHC Class II
10%
Dilution
10%
CD8+ Cell
10%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
CD4
66%
CD8
66%
Transgenic Mouse
33%
HLA-A
33%
Mouse Model
16%
Dilution
16%
Amino Acid
16%
Secretion (Process)
16%
MHC Class II
16%
HLA-DR
16%
Cytotoxic T Cell
16%
Humoral Immunity
16%
Immunogenicity
16%
MHC Class I
16%
Carboxyfluorescein Diacetate Succinimidyl Ester
16%
CD8+ Cell
16%